BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10934539)

  • 1. Predictors of Medicare costs in elderly beneficiaries with breast, colorectal, lung, or prostate cancer.
    Penberthy L; Retchin SM; McDonald MK; McClish DK; Desch CE; Riley GF; Smith TJ; Hillner BE; Newschaffer CJ
    Health Care Manag Sci; 1999 Jul; 2(3):149-60. PubMed ID: 10934539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projections of the cost of cancer care in the United States: 2010-2020.
    Mariotto AB; Yabroff KR; Shao Y; Feuer EJ; Brown ML
    J Natl Cancer Inst; 2011 Jan; 103(2):117-28. PubMed ID: 21228314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of trends in the cost of initial cancer treatment.
    Warren JL; Yabroff KR; Meekins A; Topor M; Lamont EB; Brown ML
    J Natl Cancer Inst; 2008 Jun; 100(12):888-97. PubMed ID: 18544740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.
    Yabroff KR; Warren JL; Schrag D; Mariotto A; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S56-63. PubMed ID: 19536010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer.
    Brown ML; Riley GF; Potosky AL; Etzioni RD
    Med Care; 1999 Dec; 37(12):1249-59. PubMed ID: 10599606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.
    Riley GF; Potosky AL; Lubitz JD; Kessler LG
    Med Care; 1995 Aug; 33(8):828-41. PubMed ID: 7637404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source?
    Yabroff KR; Warren JL; Banthin J; Schrag D; Mariotto A; Lawrence W; Meekins A; Topor M; Brown ML
    Med Care; 2009 Jul; 47(7 Suppl 1):S64-9. PubMed ID: 19536016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer.
    Vyas A; Madhavan SS; Sambamoorthi U; Pan XL; Regier M; Hazard H; Kalidindi S
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1401-1409. PubMed ID: 29118232
    [No Abstract]   [Full Text] [Related]  

  • 10. Potentially inappropriate medication use and associated healthcare utilization and costs among older adults with colorectal, breast, and prostate cancers.
    Feng X; Higa GM; Safarudin F; Sambamoorthi U; Tan X
    J Geriatr Oncol; 2019 Sep; 10(5):698-704. PubMed ID: 30772191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan perspective.
    Sagar B; Lin YS; Castel LD
    J Med Econ; 2017 Oct; 20(10):1018-1023. PubMed ID: 28581874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs of Cancer Care Across the Disease Continuum.
    Kaye DR; Min HS; Herrel LA; Dupree JM; Ellimoottil C; Miller DC
    Oncologist; 2018 Jul; 23(7):798-805. PubMed ID: 29567821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating health care costs related to cancer treatment from SEER-Medicare data.
    Brown ML; Riley GF; Schussler N; Etzioni R
    Med Care; 2002 Aug; 40(8 Suppl):IV-104-17. PubMed ID: 12187175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter?
    Chen AB; Li L; Cronin AM; Brooks GA; Kavanagh BD; Schrag D
    Health Serv Res; 2018 Aug; 53 Suppl 1(Suppl Suppl 1):3227-3244. PubMed ID: 28858372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical Care Costs Associated With Cancer in Integrated Delivery Systems.
    Banegas MP; Yabroff KR; O'Keeffe-Rosetti MC; Ritzwoller DP; Fishman PA; Salloum RG; Lafata JE; Hornbrook MC
    J Natl Compr Canc Netw; 2018 Apr; 16(4):402-410. PubMed ID: 29632060
    [No Abstract]   [Full Text] [Related]  

  • 16. Patient time costs associated with cancer care.
    Yabroff KR; Davis WW; Lamont EB; Fahey A; Topor M; Brown ML; Warren JL
    J Natl Cancer Inst; 2007 Jan; 99(1):14-23. PubMed ID: 17202109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Area-level variations in cancer care and outcomes.
    Keating NL; Landrum MB; Lamont EB; Bozeman SR; McNeil BJ
    Med Care; 2012 May; 50(5):366-73. PubMed ID: 22437623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of cancer-related physician services to Medicare.
    Maroongroge S; Kim SP; Mougalian S; Johung K; Decker RH; Soulos PR; Long JB; Gross CP; Yu JB
    Yale J Biol Med; 2015 Jun; 88(2):107-14. PubMed ID: 26029009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Nonconcordance With NCCN Guidelines on Resource Utilization, Cost, and Mortality in De Novo Metastatic Breast Cancer.
    Rocque GB; Williams CP; Jackson BE; Ingram SA; Halilova KI; Pisu M; Kenzik KM; Azuero A; Forero A; Bhatia S
    J Natl Compr Canc Netw; 2018 Sep; 16(9):1084-1091. PubMed ID: 30181420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.